GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹5,967 Cr | ₹5,819 Cr | ₹4,546 Cr | ₹4,689 Cr | ₹4,201 Cr |
What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹5,967 Cr |
| Mar2024 | ₹5,819 Cr |
| Mar2023 | ₹4,546 Cr |
| Mar2022 | ₹4,689 Cr |
| Mar2021 | ₹4,201 Cr |
How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,967 Cr | 2.55 | |
| Mar2024 | ₹5,819 Cr | 27.99 | |
| Mar2023 | ₹4,546 Cr | -3.05 | |
| Mar2022 | ₹4,689 Cr | 11.63 | |
| Mar2021 | ₹4,201 Cr | - | |
Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹55,256.2 Cr | -1.6% | -5.3% | 31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.6% |
-5.3% |
31.8% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses